08/30/2022
Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) or similar agents for pre-exposure prophylaxis among uninfected populations who are at risk of acquiring HIV infection.
Joshua Khalili, MD, AAHIVS, is an internal medicine physician at the Center for Clinical AIDS Research and Education at UCLA's David Geffen School of Medicine in Los Angeles, CA.
Reference:
Khalili J, Landovitz RJ. HIV preexposure prophylaxis—the role of primary care clinicians in ending the HIV epidemic [Published online November 18, 2019]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2019.5456